Does a clinical scientist led cardio-oncology clinic improve surveillance for cardio-toxicity for patients receiving trastuzumab compared to oncology services alone?
28 May 2019 (08:30 - 12:30)
Organised by:
Abstract
About the speaker
St Thomas', London (United Kingdom of Great Britain & Northern Ireland)
9 More presentations in this session
Access the full session
The Event
Heart Failure 2019
28 May 2019
08:30 CET
